Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for etoposide
Most Correlated Studies
- Genomics Assisted Toxicity Evaluation system study - Human Hepatocytes
- Etoposide-treated HEK293 cells expressing p65 wt or p65 S547A non-phosphorylable mutant
- Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
- Livers, lungs, and hearts of FVB nude mice treated with etoposide or doxorubicin
- Rhabdomyosarcoma xenografts treated with ICE-T (ifosfamide, carboplatin, etoposide and paclitaxel)
Most Relevant Literature
- Egr-1 regulates the transcription of the BRCA1 gene by etoposide.
- Reformulation of etoposide with solubility-enhancing rubusoside.
- Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor.
- Probable etoposide interaction with Echinacea.
- Effects of etoposide on the proliferation of hexaploid H1 (ES) cells.
Most Relevant Clinical Trials
- Etoposide in Patients With COVID-19 Infection
- Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
- Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
- Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer
